Literature DB >> 30297340

RNA Splicing in the Transition from B Cells to Antibody-Secreting Cells: The Influences of ELL2, Small Nuclear RNA, and Endoplasmic Reticulum Stress.

Ashley M Nelson1, Nolan T Carew1, Sage M Smith1, Christine Milcarek2.   

Abstract

In the transition from B cells to Ab-secreting cells (ASCs) many genes are induced, such as ELL2, Irf4, Prdm1, Xbp1, whereas other mRNAs do not change in abundance. Nonetheless, using splicing array technology and mouse splenic B cells plus or minus LPS, we found that induced and "uninduced" genes can show large differences in splicing patterns between the cell stages, which could influence ASC development. We found that ∼55% of these splicing changes depend on ELL2, a transcription elongation factor that influences expression levels and splicing patterns of ASC signature genes, genes in the cell-cycle and N-glycan biosynthesis and processing pathways, and the secretory versus membrane forms of the IgH mRNA. Some of these changes occur when ELL2 binds directly to the genes encoding those mRNAs, whereas some of the changes are indirect. To attempt to account for the changes that occur in RNA splicing before or without ELL2 induction, we examined the amount of the small nuclear RNA molecules and found that they were significantly decreased within 18 h of LPS stimulation and stayed low until 72 h. Correlating with this, at 18 h after LPS, endoplasmic reticulum stress and Ire1 phosphorylation are induced. Inhibiting the regulated Ire1-dependent mRNA decay with 4u8C correlates with the reduction in small nuclear RNA and changes in the normal splicing patterns at 18 h. Thus, we conclude that the RNA splicing patterns in ASCs are shaped early by endoplasmic reticulum stress and Ire1 phosphorylation and later by ELL2 induction.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30297340      PMCID: PMC6219926          DOI: 10.4049/jimmunol.1800557

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  The snRNP-associated U1A levels change following IL-6 stimulation of human B-cells.

Authors:  Christine Milcarek; Kathleen Martincic; Ling-Hsiu Chung-Ganster; Carol S Lutz
Journal:  Mol Immunol       Date:  2003-03       Impact factor: 4.407

2.  A slow RNA polymerase II affects alternative splicing in vivo.

Authors:  Manuel de la Mata; Claudio R Alonso; Sebastián Kadener; Juan P Fededa; Matías Blaustein; Federico Pelisch; Paula Cramer; David Bentley; Alberto R Kornblihtt
Journal:  Mol Cell       Date:  2003-08       Impact factor: 17.970

3.  Differential alterations in metabolic pattern of the six major UsnRNAs during development.

Authors:  R Ray; K Ray; C K Panda
Journal:  Mol Cell Biochem       Date:  1997-12       Impact factor: 3.396

4.  Transcriptional profiling of mouse B cell terminal differentiation defines a signature for antibody-secreting plasma cells.

Authors:  Wei Shi; Yang Liao; Simon N Willis; Nadine Taubenheim; Michael Inouye; David M Tarlinton; Gordon K Smyth; Philip D Hodgkin; Stephen L Nutt; Lynn M Corcoran
Journal:  Nat Immunol       Date:  2015-04-20       Impact factor: 25.606

5.  Transcription elongation factor ELL2 drives Ig secretory-specific mRNA production and the unfolded protein response.

Authors:  Kyung Soo Park; Ian Bayles; Alec Szlachta-McGinn; Joshua Paul; Julie Boiko; Patricia Santos; June Liu; Zhou Wang; Lisa Borghesi; Christine Milcarek
Journal:  J Immunol       Date:  2014-09-19       Impact factor: 5.422

6.  The endoribonuclease activity of mammalian IRE1 autoregulates its mRNA and is required for the unfolded protein response.

Authors:  W Tirasophon; K Lee; B Callaghan; A Welihinda; R J Kaufman
Journal:  Genes Dev       Date:  2000-11-01       Impact factor: 11.361

7.  Increased phosphorylation of the carboxyl-terminal domain of RNA polymerase II and loading of polyadenylation and cotranscriptional factors contribute to regulation of the ig heavy chain mRNA in plasma cells.

Authors:  Scott A Shell; Kathleen Martincic; Joseph Tran; Christine Milcarek
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

8.  Generation of functionally distinct isoforms of PTBP3 by alternative splicing and translation initiation.

Authors:  Lit-Yeen Tan; Peter Whitfield; Miriam Llorian; Elisa Monzon-Casanova; Manuel D Diaz-Munoz; Martin Turner; Christopher W J Smith
Journal:  Nucleic Acids Res       Date:  2015-05-04       Impact factor: 16.971

9.  Limiting of the innate immune response by SF3A-dependent control of MyD88 alternative mRNA splicing.

Authors:  Lesly De Arras; Scott Alper
Journal:  PLoS Genet       Date:  2013-10-24       Impact factor: 5.917

10.  Regulated Ire1-dependent decay of messenger RNAs in mammalian cells.

Authors:  Julie Hollien; Jonathan H Lin; Han Li; Nicole Stevens; Peter Walter; Jonathan S Weissman
Journal:  J Cell Biol       Date:  2009-08-03       Impact factor: 10.539

View more
  6 in total

1.  Derivation of splice junction-specific antibodies using a unique hapten targeting strategy and directed evolution.

Authors:  Emily P Fuller; Rachel J O'Neill; Michael P Weiner
Journal:  N Biotechnol       Date:  2022-06-22       Impact factor: 6.490

2.  NF-κB mediates lipopolysaccharide-induced alternative pre-mRNA splicing of MyD88 in mouse macrophages.

Authors:  Frank Fang-Yao Lee; Kevin Davidson; Chelsea Harris; Jazalle McClendon; William J Janssen; Scott Alper
Journal:  J Biol Chem       Date:  2020-03-16       Impact factor: 5.157

Review 3.  The three as: Alternative splicing, alternative polyadenylation and their impact on apoptosis in immune function.

Authors:  Davia Blake; Kristen W Lynch
Journal:  Immunol Rev       Date:  2021-08-08       Impact factor: 12.988

Review 4.  Genome edited B cells: a new frontier in immune cell therapies.

Authors:  Geoffrey L Rogers; Paula M Cannon
Journal:  Mol Ther       Date:  2021-09-24       Impact factor: 11.454

Review 5.  Endoplasmic Reticulum Stress of Gut Enterocyte and Intestinal Diseases.

Authors:  Han Gao; Chengwei He; Rongxuan Hua; Yuexin Guo; Boya Wang; Chen Liang; Lei Gao; Hongwei Shang; Jing-Dong Xu
Journal:  Front Mol Biosci       Date:  2022-03-24

6.  Characterizing the Interaction between the HTLV-1 Transactivator Tax-1 with Transcription Elongation Factor ELL2 and Its Impact on Viral Transactivation.

Authors:  Stephan Kohrt; Sarah Strobel; Melanie C Mann; Heinrich Sticht; Bernhard Fleckenstein; Andrea K Thoma-Kress
Journal:  Int J Mol Sci       Date:  2021-12-18       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.